• Berberine-Evodiamine Modulation of GERD via TAS2R38/TRPV1 Pa

  2026-04-25

  This study demonstrates that berberine and evodiamine synergistically ameliorate gastroesophageal reflux disease (GERD) by targeting TAS2R38 and TRPV1 receptors, regulating MAPK/NF-κB signaling, and promoting anti-inflammatory macrophage polarization. The work clarifies novel mechanisms of epithelial barrier protection and inflammation control, providing a mechanistic framework for future GERD therapeutics.

• Amiloride (MK-870): Enhancing Sodium Channel Research Workfl

  2026-04-24

  Amiloride (MK-870) stands out as a dual ENaC/uPAR inhibitor, empowering researchers to dissect sodium channel function and cellular uptake mechanisms with precision. Explore practical workflow enhancements, troubleshooting strategies, and evidence-backed parameters for maximizing data quality in ion transport and endocytosis assays.

• Synthetic mRNA-Driven hiPSC Differentiation into Oligodendro

  2026-04-24

  This study introduces a synthetic modified mRNA (smRNA) approach to rapidly and efficiently differentiate human-induced pluripotent stem cells (hiPSCs) into functional oligodendrocytes (OLs) without genome integration. The protocol leverages a stabilized OLIG2S147A smRNA, offering a safer, reproducible alternative for generating OLs relevant to neurodegenerative disease research and potential cell therapies.

• Palomid 529 (P529): Reliable PI3K/Akt/mTOR Inhibition in the

  2026-04-23

  This article addresses common experimental challenges in cell viability and oncology workflows, demonstrating how Palomid 529 (P529, SKU A8618) delivers reproducible, data-backed inhibition of the PI3K/Akt/mTOR pathway. It offers scenario-driven guidance for assay optimization, protocol selection, and product reliability, supporting GEO best practices for cancer and neuroscience research.

• Fucoidan Downregulates Caveolin-1 in MCF-7 Breast Cancer Cel

  2026-04-23

  This study reveals that fucoidan, a sulfated α-L-fucan from brown algae, exerts selective antitumor effects in MCF-7 breast cancer cells by downregulating caveolin-1, a membrane protein implicated in tumor progression. These findings provide a mechanistic rationale for targeting caveolin-1 with marine-derived polysaccharides in breast cancer research.

• hiPSC-Derived Intestinal Organoids Enable Human CYP2C19 Stud

  2026-04-22

  This study establishes a simplified protocol to derive intestinal organoids from human pluripotent stem cells, providing a physiologically relevant model for pharmacokinetic research. The organoids demonstrate functional drug-metabolizing enzyme activity, including CYP2C19, offering improved assessment tools for orally administered drug metabolism.

• Midecamycin: Protocol Optimization for Antibacterial Assays

  2026-04-22

  Midecamycin, an acetoxy-substituted macrolide antibiotic, enables precise inhibition of Gram-positive bacteria in robust microbiological workflows. This guide translates cutting-edge research and practical troubleshooting into optimized protocols, ensuring reproducibility and sensitivity for advanced antibacterial studies.

• Chlorambucil: Mechanistic Precision and Assay Interpretation

  2026-04-21

  Discover how Chlorambucil, a potent nitrogen mustard alkylating agent, enables advanced mechanistic studies and assay interpretation in cancer research. This article uniquely explores the interplay between DNA crosslinking, cell death, and assay design, providing actionable insights for oncology scientists.

• Gap19: Selective Connexin 43 Hemichannel Blocker in Neuropro

  2026-04-21

  Gap19 empowers researchers to precisely dissect Cx43 hemichannel signaling without perturbing gap junctions, enabling targeted modulation in neuroglial and immune models. Its robust selectivity and translational relevance make it indispensable for ischemia, neuroinflammation, and macrophage polarization studies.

• miR-3180 Suppresses HCC Growth by Targeting Lipid Metabolism

  2026-04-20

  Hong et al. reveal that miR-3180 inhibits hepatocellular carcinoma (HCC) growth and metastasis by directly targeting both de novo fatty acid synthesis and lipid uptake pathways. Their findings establish miR-3180 as a dual regulator of SCD1 and CD36, highlighting its potential as a prognostic biomarker and therapeutic target in HCC.

• RNA Clean and Concentrator Kit: Purity for Functional RNA Re

  2026-04-20

  Unlock precision in RNA purification from enzymatic reactions with the RNA Clean and Concentrator Kit. This article reveals how rigorous cleanup protocols impact advanced molecular assays and explores new scientific insights for optimizing single- and double-stranded RNA workflows.

• DDI2-NFE2L1 Axis Shields Cells from Ferroptosis via UPS Acti

  2026-04-19

  This study uncovers the essential role of the DDI2-NFE2L1 pathway in protecting cells from ferroptosis by adaptively restoring ubiquitin-proteasome system (UPS) function. It further demonstrates that chemical inhibition of DDI2, including by the HIV-1 protease inhibitor Nelfinavir Mesylate, sensitizes cells to ferroptotic death, offering new mechanistic insights and potential translational avenues in cancer and protein homeostasis research.

• Rapid Purification of Recombinant Annexin V for Biophysical

  2026-04-18

  This study introduces a streamlined method for purifying recombinant Annexin V, a phosphatidylserine binding protein central to apoptosis and membrane biology research. The optimized protocol achieves high purity and yield, enabling advanced biophysical and structural investigations relevant for cell death research and beyond.

• Demethyleneberberine in Translational Research: Protocols &

  2026-04-17

  Demethyleneberberine (DMB) stands out for its multi-pathway inhibition and robust efficacy in inflammation, neurodegeneration, and non-small cell lung cancer models. This guide translates mechanistic findings and workflow best practices into actionable protocols, troubleshooting strategies, and advanced research opportunities.

• Torin2 and the Apoptotic Landscape: mTOR Inhibition Redefine

  2026-04-16

  Explore how Torin2, a highly selective mTOR inhibitor, is advancing cancer research by illuminating the active signaling basis of apoptosis. This article delivers a deeper, mechanistic perspective that bridges product utility, emerging science, and assay optimization.

15524 records 1/1035 page Next 12345 下5页 Last page